Dai Guohua, Song Xianbo, Ma Peize, Liu Ning, Yao Jing
Department of Cardiology, Affiliated Hospital of Shandong University of TCM, Jinan 250014, China. Email:
Department of Cardiology, Affiliated Hospital of Shandong University of TCM, Jinan 250014, China.
Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Dec;42(12):1039-47.
To explore the role of microRNA on the myocardial microvascular endothelial cells (CMECs) of ischemic heart rats in the process of angiogenesis and related regulation mechanism.
Myocardial ischemic rats model was established by coronary ligation.Seven days after operation, the ischemic CMECs were cultured by the method of planting myocardium tissue and identified by immunocytochemistry to observe the biological characteristics of ischemic CMECs angiogenesis, to determine the window period of migration, proliferation, tube formation in the process of its angiogenesis. Dynamic expression changes of microRNA in the process of ischemic CMECs angiogenesis was detected using microRNA chip and further verified by real-time PCR, the core microRNA of the ischemic CMECs was defined and the predicted target genes of core microRNA were determined by bioinformatics methods and real-time PCR. At the same time, the protein expression of target gene and angiogenesis related genes of p38MAPK, PI3K,Akt,VEGF were measured by Western blot.
The CMECs of rats presented typical characteristics of microvascular endothelial cells, and factor VIII, CD31 related antigens were all positively stained by immunocytochemical analysis. The migration window period was on the first day, and the tube formation window period was on the second day of both control and ischemic groups, while the proliferation window period was on the third day for the normal group, and the sixth day for ischemic group. According to the expressional difference and their relationship with angiogenesis, miRNA-223-3p was ultimately determined as the core microRNA in the process of ischemic CMECs angiogenesis, real-time PCR verified this hypothesis. Bioinformatics methods predicted that Rps6kb1 is the target genes of miRNA-223-3p, the pathway analysis showed that Rps6kb1 could regulate angiogenesis via HIF-1α signal pathway. Moreover, the mRNA and protein expression of VEGF, p38MAPK, PI3K,Akt, which were the downstream molecules of Rps6kb1/HIF-1α signal pathway, were also significantly downregulated in ischemic CMECs from migration and proliferation stage.
Our results show that the miRNA-223-3p is the core microRNA of ischemic CMECs angiogenesis. MiRNA-223-3p could regulate Rps6kb1/HIF-1α signal pathway, inhibit the process of migration and proliferation of ischemic CMECs angiogenesis. MiRNA-223-3p is thus likely to be a core target for enhancing angiogenesis of ischemic heart disease.
探讨微小RNA在缺血性心脏病大鼠心肌微血管内皮细胞(CMECs)血管生成过程中的作用及相关调控机制。
采用冠状动脉结扎法建立心肌缺血大鼠模型。术后7天,采用种植心肌组织法培养缺血CMECs,并通过免疫细胞化学进行鉴定,观察缺血CMECs血管生成的生物学特性,确定其血管生成过程中迁移、增殖、管腔形成的窗口期。利用微小RNA芯片检测缺血CMECs血管生成过程中微小RNA的动态表达变化,并通过实时荧光定量PCR进一步验证,确定缺血CMECs的核心微小RNA,采用生物信息学方法及实时荧光定量PCR确定核心微小RNA的预测靶基因。同时,通过蛋白质免疫印迹法检测靶基因及p38MAPK、PI3K、Akt、VEGF等血管生成相关基因的蛋白表达。
大鼠CMECs呈现微血管内皮细胞的典型特征,免疫细胞化学分析显示因子VIII、CD31相关抗原均呈阳性染色。对照组和缺血组的迁移窗口期均为第1天,管腔形成窗口期均为第2天,正常组的增殖窗口期为第3天,缺血组为第6天。根据表达差异及其与血管生成的关系,最终确定miRNA-223-3p为缺血CMECs血管生成过程中的核心微小RNA,实时荧光定量PCR验证了这一假设。生物信息学方法预测Rps6kb1是miRNA-223-3p的靶基因,通路分析显示Rps6kb1可通过HIF-1α信号通路调控血管生成。此外,在缺血CMECs从迁移和增殖阶段,Rps6kb1/HIF-1α信号通路下游分子VEGF、p38MAPK、PI3K、Akt的mRNA和蛋白表达也显著下调。
我们的结果表明,miRNA-223-3p是缺血CMECs血管生成的核心微小RNA。miRNA-223-3p可调控Rps6kb1/HIF-1α信号通路,抑制缺血CMECs血管生成的迁移和增殖过程。因此,miRNA-223-3p可能是增强缺血性心脏病血管生成的核心靶点。